中国新药杂志

应用整体自显影定量技术开展的单多次给药后大鼠组织分布比较研究

PDF下载

何隆孟 ¹ , 熊雅婷 ¹ , 冯浩 ² , 喻振文 ¹ , 吴磊 ¹ , 朱轩轩 ¹ , 顾哲明 ³

中国新药杂志 | 实验研究 2021,30(3): 259-266

收起

中国新药杂志 |实验研究 2021 , 30 (3) : 259 -266

应用整体自显影定量技术开展的单多次给药后大鼠组织分布比较研究

全屏

何隆孟¹, 熊雅婷¹, 冯浩², 喻振文¹, 吴磊¹, 朱轩轩¹, 顾哲明³

作者信息

¹江苏万略医药科技有限公司，南京　211800

²深圳万略医药科技有限公司，深圳　518000

³成都中医药大学，成都　610075

通讯作者:

顾哲明，男，教授，主要从事药动学研究。E-mail：gu_zheming@walueps.com。

作者简介:

何隆孟，男，硕士，主要从事药动学研究。E-mail：he_longmeng@walueps.com。

Tissue distribution by quantitative whole body autoradiography after single and repeated administration in rats

Long-meng HE¹, Ya-ting XIONG¹, Hao FENG², Zhen-wen YU¹, Lei WU¹, Xuan-xuan ZHU¹, Zhe-ming GU³

Affiliations

¹Value Pharmaceutical Service Co., Ltd., Nanjing 211800, China

²Value Pharmaceutical Service Co., Ltd., Shenzhen 518000, China

³Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China

出版时间: 2021-02-15

文章导航

摘要

收起

目的：

应用整体自显影定量技术（QWBA），比较单次和重复多次给药后大鼠体内的组织分布情况，以指导人体放射性物质平衡试验设计。

方法：

按15 mg·kg^-1剂量，分别灌胃给予雄性Long-Evans（LE）大鼠0，7和14次的非放射性标记药物VPS-01（qd）24 h后单次灌胃给予100 μCi/15 mg·kg^-1的[¹⁴C]VPS-01（分别定义为0+1，7+1和14+1给药组）；于给予放射性标记药物后的3，24，168和504 h每组处死1只大鼠，收集尸体并立即冷冻。使用大型冰冻切片机（Leica CM3600 XP）切片，适当处理后使用磷显像技术获得切片中各组织和感兴趣区域的放射性强度。

结果：

采用3种不同方式给药后总放射性均广泛分布于各组织中，VPS-01和/或其相关代谢产物与黑色素存在结合的现象。与0+1给药组比，7+1给药组中大鼠各组织放射性浓度及暴露量均显著降低；据大鼠组织暴露量估算的人体单次口服[¹⁴C]VPS-01可给予的最大放射性剂量从61.6增加到611 μCi。14+1给药组大鼠的组织放射性浓度和暴露量更低，但与7+1组无显著性差异。

结论：

具有组织共价结合导致体内消除缓慢的药物在物质平衡试验中易引起人体放射性暴露量高，如先重复给予受试者数次非放射性标记药物，待人体内达到稳态后单次给予¹⁴C-标记药物，可显著降低受试者辐射暴露、加大人体放射性剂量可选择范围并增加循环血液中放射性浓度而易于代谢产物的鉴定。

关键词

整体自显影技术 / 组织分布 / 人体放射性给药剂量 / 物质平衡

Abstract

收起

Objective:

Tissue distribution after single and repeated doses in rats was compared by quantitative whole body autoradiography technique (QWBA) to guide the design of human radioactive mass balance study.

Methods:

Male Long Evans (LE) rats were given, by gavage, 0, 7 and 14 doses (once a day) of non-radiolabeled drug VPS-01, at 15 mg·kg^-1, followed by a single dose of [¹⁴C]VPS-01 at 100 μCi/15 mg·kg^-1, po, at 24 h post last non-radioactive dose (defined as 0+1, 7+1 and 14+1 groups, respectively). And then, after 3, 24, 168 and 504 h of radiolabeled drug administration, one rat from each group was sacrificed and carcasses were collected and frozen immediately, followed by sliced using Leica CM3600 XP. After proper treatment, the radioactivity level of each tissue and region of interest in the slices were obtained by phosphorus imaging technology.

Results:

The total radioactivity of VPS-01 and/or its related metabolites was observed bound to melanin. Compared with 0+1 group, the radiation concentration and exposure of rats in 7+1 group significantly reduced, and the maximum radiation dose of [¹⁴C]VPS-01 in humans could accordingly increase from 61.6 μCi to 611 μCi. However, no significant difference of exposure was observed between 14+1 group and 7+1 group.

Conclusion:

Drugs with slow elimination due to tissue covalent binding are easy to result in high radiation exposure in the human body in the mass balance study. If the subjects are given non-radiolabeled drugs repeatedly for several times to reach a steady state in human body before a single dose of the ¹⁴C-drug is given, the radiation exposure of subjects can be significantly reduced, the optional range of human radiation dose can be increased, and the radioactivity in the circulating blood will be increased, facilitating metabolite identification.

Key words

quantitative whole body autoradiography / tissue distribution / dosimetry / mass balance

引用本文

何隆孟, 熊雅婷, 冯浩, 喻振文, 吴磊, 朱轩轩, 顾哲明. 应用整体自显影定量技术开展的单多次给药后大鼠组织分布比较研究. 中国新药杂志, 2021 , 30 (3) : 259 -266 .

Long-meng HE, Ya-ting XIONG, Hao FENG, Zhen-wen YU, Lei WU, Xuan-xuan ZHU, Zhe-ming GU. Tissue distribution by quantitative whole body autoradiography after single and repeated administration in rats[J]. Chinese Journal of New Drugs, 2021 , 30 (3) : 259 -266 .

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

[1]

国家药品监督管理局. 药物代谢产物安全性试验技术指导原则[EB/OL]. (2012). http://www.cde.org.cn.

[2]

US Food and Drug Administration. Guidance for industry: safety testing of drug metabolites, US Department of Health and Human Services[EB/OL]. (2020). https://www.fda.gov/media/72279/download.

[3]

国家药品监督管理局. 药物相互作用研究指导原则[EB/OL]. (2012). http://www.cde.org.cn.

[4]

European Medicines Agency. Guideline on the evaluation of anticancer medicinal products in man, Oncology Working Party[EB/OL]. (2013). http://www.ema.europa.eu.

[5]

International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. S9 Nonclinical Evaluation for anticancer pharmaceuticals[EB/OL]. (2010). http://www.fda.gov.

[6]

COPPOLA P, ANDERSSON A, COLE S. The importance of the human mass balance study in regulatory submissions[J]. CPT Pharmacometrics Syst Pharmacol, 2019, 8(11): 792-804.

[7]

国家药品监督管理局. 药物非临床药代动力学研究技术指导原则[EB/OL]. (2014). http://www.cde.org.cn.

[8]

DICKINSON PA, CANTARINI MV, COLLIER J, et al. Metabolic disposition of Osimertinib in rats, dogs, and humans: insights into a drug designed to bind covalently to a cysteine residue of epidermal growth factor receptor[J]. Drug Metab Dispos, 2016, 44: 1201-1212.

[9]

European Medicines Agency. Guideline on the investigation of drug interactions. Committee for Human Medicinal Products[EB/OL]. (2013). http://www.ema.europa.eu.

[10]

SOLONA EG, LEE F. Methods determining phosphor imaging limits of quantitation in whole-body autoradiography rodent tissue distribution studies affect predictions of ¹⁴C human dosimetry[J]. J Pharmacol Toxicol, 2002, 46: 83-91.

[11]

AKIYO S. MICHIAKI, A. Proposition for assessment of quantitative whole-body autoradiography[J]. Exp Mol Pathol, 1999, 67: 75-90.

[12]

ICRP Publication 53, Radiation dose to patients from radiopharmaceuticals[M]. Ann ICRP, 1988: 1-4.

[13]

褚超男, 黄琪. 阿帕替尼治疗复发性卵巢癌的疗效及安全性评价[J]. 中国新药杂志, 2020, 29(3): 299-302.

[14]

GOLDINGER SM, RINDERKNECHT J, DUMMER R, et al. A single-dose mass balance and metabolite-profiling study of vemurafenib in patients with metastatic melanoma[J]. Pharmacol Res Perspect, 2015, 3: e00113.

[15]

GOKULGANDHI MR, VADLAPUDI AD, MITRA AK. Ocular toxicity from systemically administered xenobiotics[J]. Expert Opin Drug Metab Toxicol, 2012, 8(10): 1277-1291.

[16]

21 CFR 361.1 Radioactive Drugs for Certain Research Uses[EB/OL]. https://www.accessdata.fda.gov.

[17]

NIJENHUIS CM, SCHELLENS JH, BEIJNEN JH. Regulatory aspects of human radiolabeled mass balance studies in oncology: concise review[J]. Drug Metab Rev, 2016, 48(2): 266-280.

[18]

孙杰, 郑钊铖, 石劲敏, 等. 定量全身放射性自显影技术(QWBA)在大鼠组织分布研究中的应用[J]. 毒理学杂志, 2018, 32(5): 390-392.

[19]

SCHWEITZER A. Contribution of quantitative whole-body autoradioluminography to the early selection and development of drug candidates[M]. Springer, 2011: 243-259.

2021年第30卷第3期

PDF下载

引用本文

BibTeX

文章信息

首发时间：2026-10-29
出版时间：2021-02-15

补充材料

相关文章

文章信息

作者

出版历史

录用日期：2020-11-16

基金

作者信息

¹江苏万略医药科技有限公司，南京　211800

²深圳万略医药科技有限公司，深圳　518000

³成都中医药大学，成都　610075

通讯作者:

顾哲明，男，教授，主要从事药动学研究。E-mail：gu_zheming@walueps.com。

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1322627033184719459

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT